ES2156218T3 - Composiciones liposomicas conteniendo un hibrido de interferon. - Google Patents

Composiciones liposomicas conteniendo un hibrido de interferon.

Info

Publication number
ES2156218T3
ES2156218T3 ES95938532T ES95938532T ES2156218T3 ES 2156218 T3 ES2156218 T3 ES 2156218T3 ES 95938532 T ES95938532 T ES 95938532T ES 95938532 T ES95938532 T ES 95938532T ES 2156218 T3 ES2156218 T3 ES 2156218T3
Authority
ES
Spain
Prior art keywords
interfer
hybrid
compositions containing
phospholipids
liposomic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95938532T
Other languages
English (en)
Inventor
Peter William Taylor
Mohammed Akhlaq
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2156218T3 publication Critical patent/ES2156218T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UN COMPUESTO FARMACEUTICO QUE INCLUYE UN HIBRIDO DE AL INTERFERON CONTENIDO EN LIPOSOMAS DE UNA MEZCLA DE LIPIDOS DE COLESTEROL JUNTO CON AL MENOS DOS FOSFOLIPIDOS, DE LOS CUALES AL MENOS UNO ESTA CARGADO, Y AL MENOS UNO DE LOS FOSFOLIPIDOS ES NEUTRO.
ES95938532T 1994-12-08 1995-12-04 Composiciones liposomicas conteniendo un hibrido de interferon. Expired - Lifetime ES2156218T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9426484.3A GB9426484D0 (en) 1994-12-08 1994-12-08 Compositions

Publications (1)

Publication Number Publication Date
ES2156218T3 true ES2156218T3 (es) 2001-06-16

Family

ID=10766773

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95938532T Expired - Lifetime ES2156218T3 (es) 1994-12-08 1995-12-04 Composiciones liposomicas conteniendo un hibrido de interferon.

Country Status (12)

Country Link
EP (1) EP0799027B1 (es)
JP (1) JPH10510254A (es)
AT (1) ATE199315T1 (es)
AU (1) AU3989295A (es)
CA (1) CA2207292A1 (es)
DE (1) DE69520231T2 (es)
DK (1) DK0799027T3 (es)
ES (1) ES2156218T3 (es)
GB (1) GB9426484D0 (es)
GR (1) GR3035844T3 (es)
PT (1) PT799027E (es)
WO (1) WO1996017596A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006127360A2 (en) * 2005-05-23 2006-11-30 Sdg, Inc. Lipid construct for delivery of interferon to a mammal
EP1909758A1 (en) * 2005-08-02 2008-04-16 I.D.M. Immuno-Designed Molecules Process for the preparation of liposomal formulations
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
US11077173B2 (en) 2017-03-13 2021-08-03 Sdg, Inc. Lipid-based nanoparticles and methods using same
SG11201908052PA (en) 2017-03-13 2019-09-27 Sdg Inc Lipid-based nanoparticles with enhanced stability

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2964024D1 (en) * 1978-10-02 1982-12-16 Procter & Gamble Liposomes for drug delivery and composition containing a liposome drug system
US5023087A (en) * 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US4855090A (en) * 1987-03-13 1989-08-08 Micro-Pak, Inc. Method of producing high aqueous volume multilamellar vesicles
US4997652A (en) * 1987-12-22 1991-03-05 Visionex Biodegradable ocular implants
EP0331635A3 (en) * 1988-02-29 1990-02-28 The Board of Regents of the University of Texas System Preparations for treating bladder cancer
US5077057A (en) * 1989-04-05 1991-12-31 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
DE4402867C1 (de) * 1994-01-31 1995-06-14 Rentschler Arzneimittel Liposomen enthaltend darin verkapselte Proteine, Verfahren zu ihrer Herstellung sowie diese Liposomen enthaltende pharmazeutische und kosmetische Zubereitungen

Also Published As

Publication number Publication date
DE69520231D1 (de) 2001-04-05
WO1996017596A1 (en) 1996-06-13
PT799027E (pt) 2001-07-31
GB9426484D0 (en) 1995-03-08
EP0799027B1 (en) 2001-02-28
JPH10510254A (ja) 1998-10-06
ATE199315T1 (de) 2001-03-15
CA2207292A1 (en) 1996-06-13
AU3989295A (en) 1996-06-26
GR3035844T3 (en) 2001-08-31
DE69520231T2 (de) 2001-08-16
DK0799027T3 (da) 2001-06-18
EP0799027A1 (en) 1997-10-08

Similar Documents

Publication Publication Date Title
AU3559895A (en) Polyethylene glycol modified ceramide lipids and liposome uses thereof
AU9260898A (en) Stable particulate complexes with neutral or negative global charge of lamellar structure
ATE192657T1 (de) Arzneistoffzusammensetzung, die ein nukleinsäurecopolymer enthält
GR3030206T3 (en) Cationic lipids.
AU7071896A (en) Compositions with anti-apoptotic activity, containing a mixture of phospholipids
CA2186588A1 (en) Novel Cationic Phospholipids for Transfection
AU3780497A (en) Improvements in or relating to contrast agents
HK1054201A1 (en) Lipid complexes and liposomes of highly insoluble platinum complexes.
CA2270396A1 (en) Cationic reagents for transfection
MY100058A (en) A bread or other cereal-based food improver composition
DE69519802D1 (de) Etherlipid-liposomen und deren therapeutische verwendung
IL79356A0 (en) 1-substituted oxindole-3-carboxamides,their preparation and pharmaceutical compositions containing them
ES2118629T3 (es) Mezcla de grasas conteniendo fosfolipidos con acidos grasos lcp
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
ES2156218T3 (es) Composiciones liposomicas conteniendo un hibrido de interferon.
BG102838A (en) Compositions containing hiv protease inhibitor such as vx 478, and water soluble vitamin b as vitamin e-trgs
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
GB2188900B (en) Fusogenic phospholipid vesicles.
AU1573495A (en) {4-hexadecyl-3-methoxy-butyl} phosphonic acid and its protienconjugates useful as anti-cancer agents
NZ334634A (en) Use of a protein extracted from mammalian liver for treating HIV
EP1123147B8 (en) Jig-saw puzzle
KR960025152U (ko) 하이브리드 플라즈마 디스플레이 패널

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 799027

Country of ref document: ES